ReWalk Robotics (LFWD) vs. Its Peers Critical Review

ReWalk Robotics (NASDAQ:LFWDGet Free Report) is one of 48 public companies in the “Surgical appliances & supplies” industry, but how does it contrast to its competitors? We will compare ReWalk Robotics to related companies based on the strength of its institutional ownership, analyst recommendations, dividends, valuation, risk, profitability and earnings.

Risk and Volatility

ReWalk Robotics has a beta of 2, suggesting that its share price is 100% more volatile than the S&P 500. Comparatively, ReWalk Robotics’ competitors have a beta of 0.91, suggesting that their average share price is 9% less volatile than the S&P 500.

Profitability

This table compares ReWalk Robotics and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
ReWalk Robotics -159.76% -28.19% -23.29%
ReWalk Robotics Competitors -60.73% -66.23% -14.11%

Institutional & Insider Ownership

26.8% of ReWalk Robotics shares are owned by institutional investors. Comparatively, 45.5% of shares of all “Surgical appliances & supplies” companies are owned by institutional investors. 2.1% of ReWalk Robotics shares are owned by insiders. Comparatively, 9.2% of shares of all “Surgical appliances & supplies” companies are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Earnings & Valuation

This table compares ReWalk Robotics and its competitors top-line revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
ReWalk Robotics $13.85 million -$22.13 million -1.77
ReWalk Robotics Competitors $1.45 billion $153.17 million 23.99

ReWalk Robotics’ competitors have higher revenue and earnings than ReWalk Robotics. ReWalk Robotics is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Analyst Ratings

This is a breakdown of current ratings and price targets for ReWalk Robotics and its competitors, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ReWalk Robotics 0 0 1 0 3.00
ReWalk Robotics Competitors 340 1175 2279 98 2.55

ReWalk Robotics currently has a consensus target price of $21.00, suggesting a potential upside of 312.57%. As a group, “Surgical appliances & supplies” companies have a potential upside of 7.51%. Given ReWalk Robotics’ stronger consensus rating and higher probable upside, equities research analysts plainly believe ReWalk Robotics is more favorable than its competitors.

Summary

ReWalk Robotics competitors beat ReWalk Robotics on 8 of the 13 factors compared.

ReWalk Robotics Company Profile

(Get Free Report)

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.

Receive News & Ratings for ReWalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.